Tumor Burden Thresholds Associated with Successful Downstaging After Yttrium-90 Radioembolization in Hepatocellular Carcinoma Beyond UCSF Criteria. [PDF]
Chiu CH +8 more
europepmc +1 more source
Sequential Yttrium-90 radioembolization integrated with multimodal therapy for platinum-resistant ovarian cancer liver metastases. [PDF]
Wahl A +5 more
europepmc +1 more source
Real World Outcomes of Prescribed Ablative Dose Yttrium-90 Resin Selective Internal Radiation Therapy of Hepatocellular Carcinoma. [PDF]
Koo SX +8 more
europepmc +1 more source
Yttrium-90 radioembolization as an in vivo immune modulator: clinical evidence and pharmacologic implications. [PDF]
Tang S, Cai J, Wu P, Wang G.
europepmc +1 more source
Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches. [PDF]
Kono Y +3 more
europepmc +1 more source
Yttrium-90 for the treatment of breast cancer liver metastases: a global propensity-matched study. [PDF]
Miles B, Mallepally A, Oza Q, Moss J.
europepmc +1 more source
Yttrium-90 Radioembolization Versus Transarterial Embolization for Lung Carcinoid Hepatic Metastasis. [PDF]
Yuan G +10 more
europepmc +1 more source
Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma. [PDF]
Lin H, Tan Q.
europepmc +1 more source
Utility of Yttrium-90 Radioembolization for the Treatment of Fibrolamellar Hepatocellular Carcinoma: A Tertiary Cancer Center Experience. [PDF]
Khavandi MM +11 more
europepmc +1 more source
Yttrium-90 Radioembolization as a Safe and Effective Treatment Option for Hepatic Uveal Melanoma Metastases. [PDF]
Ni JR, Quirk M, Chmielowski B, Padia SA.
europepmc +1 more source

